U.S. Stock News

Stryker (NYSE:SYK) has completed its acquisition of Amplitude Vascular Systems, adding new peripheral vascular technology focused on arterial disease. A law firm has launched a securities investigation into Stryker related to the March cyberattack and its reported impact on financial results. These developments come as Stryker continues recent M&A activity, following its Inari Medical deal, while also facing fresh legal and regulatory scrutiny. Stryker enters these headlines with shares at...

News Corp (NWSA) has just reported Q2 2026 results, with revenue of US$2.4b and basic EPS of US$0.34, while trailing 12 month revenue stands at US$8.6b and EPS at US$0.78, supported by net income from ongoing operations of US$193 million in the quarter and US$439 million over the last year. The company has seen quarterly revenue range from US$2.1b to US$2.4b over the last six reported periods, with basic EPS moving between roughly US$0.09 and US$0.40. This gives investors a clear read on how...

In April 2026, IXT, a full MVNO specializing in secure IoT connectivity, announced it had integrated Zscaler’s Zero Trust Network Access into its SecureNet cellular platform at the SIM level, routing all device traffic through the Zscaler Zero Trust Exchange for inspection and policy enforcement. This move extends Zero Trust controls directly into global cellular infrastructure for high‑security, NIS2‑regulated industries, reducing reliance on VPNs and software agents for protecting widely...

Why Arch Capital Group (ACGL) is back in focus Arch Capital Group (ACGL) has drawn fresh attention after its first quarter 2026 results showed net income of US$1,047 million and higher earnings per share, alongside a completed share repurchase that reduced the share count. See our latest analysis for Arch Capital Group. Despite the strong first quarter update and completed buyback, the share price has slipped over the past three months, with a 90 day share price return showing a 6.37%...

In early May 2026, Freshpet reported first-quarter net sales of US$297.64 million, a swing to net income of US$48.51 million and higher full-year 2026 net sales growth guidance to 8%–11%. Beyond the headline numbers, the return to profitability alongside raised sales expectations suggests that Freshpet’s operational changes and brand investments are starting to translate into financial progress. With Freshpet now profitable and lifting its 2026 sales outlook, we’ll examine how this improved...

Why Exelon Stock Is Drawing Attention Now Exelon (EXC) has been on investors’ radar after recent share price moves, with the stock showing a 1-day return of 1.36% and a 9.46% decline over the past month. See our latest analysis for Exelon. Despite the recent 9.46% 1-month share price decline and a softer 7-day move, Exelon’s 1-year total shareholder return of 1.97% and 5-year total shareholder return of 65.72% suggest longer term holders have still seen positive results. This indicates...

In early May 2026, Himax Technologies reported first-quarter 2026 results showing revenue of US$199.01 million and net income of US$7.99 million, alongside guidance for sequential revenue and earnings growth in the second quarter. The company also declared an annual cash dividend of US$0.252 per ADS, equal to a 100% payout of last year's profit, underscoring management’s confidence in its balance sheet and cash generation while it ramps automotive, AI, and optical technologies. We’ll now...

Recent performance snapshot for Titan America Titan America (TTAM) has drawn attention after recent share price swings, with a 1 day decline of 1.53%, a month gain of 11.82%, and a 10.24% decline over the past 3 months. See our latest analysis for Titan America. Short term momentum around Titan America's US$16.75 share price has been choppy, but the 1 year total shareholder return of 22.55% points to stronger performance over a longer horizon. If Titan America's recent swings have you...

As you might know, Primoris Services Corporation ( NYSE:PRIM ) last week released its latest first-quarter, and things...

Corcept Therapeutics reported long term survival data from its DAZALS Phase 2 trial of dazucorilant in ALS. Patients receiving 300 mg daily experienced an 87% reduction in risk of death at two years. The trial did not meet its primary functional endpoint, but the survival benefit attracted attention at the ENCALS 2025 meeting. For investors tracking NasdaqCM:CORT, this new ALS data adds another layer to the story around Corcept Therapeutics beyond its core cortisol modulation work. The...

Marcus & Millichap, Inc. recently reported first-quarter 2026 results, with revenue rising to US$171.47 million from US$145.04 million a year earlier and net loss narrowing to US$3.1 million from US$4.42 million. The combination of higher revenue and a smaller loss suggests early signs of operating improvement, even as the business remains in loss-making territory. We’ll now examine how this improved revenue performance and reduced loss shape Marcus & Millichap’s existing investment...

Why Hycroft Mining Holding (HYMC) Is Back in Focus Hycroft Mining Holding (HYMC) has drawn fresh attention after reporting a wider first quarter net loss, alongside a securities law investigation examining potential false or misleading disclosures to investors. See our latest analysis for Hycroft Mining Holding. The stock has swung sharply over the past year, with a 59.34% year-to-date share price return and a very large 1-year total shareholder return, while the recent net loss and...

Why Oracle Stock Is Back in Focus Oracle (ORCL) has drawn fresh attention after its recent share price moves, with the stock closing at $194.59 and posting double digit returns over the past month and past 3 months. See our latest analysis for Oracle. For context, the recent surge in Oracle's share price, including a 20.57% 7 day share price return and 35.92% 30 day share price return, sits alongside a 30.77% 1 year total shareholder return and triple digit 3 and 5 year total shareholder...

Why Kemper Stock Is On Investors’ Radar Kemper (KMPR) has drawn attention after a stretch of weak share performance, with the stock down over the past day, week, month and past 3 months, and about 52% lower over the past year. For investors, that backdrop, alongside reported annual revenue of US$4,704.8 million and net income of US$41.9 million, raises practical questions about how to think about the company’s current valuation and risk profile. See our latest analysis for Kemper. Recent...

If you are wondering whether Micron Technology's share price still reflects fair value after a strong run, the key question is what the current market price is really paying for. The stock last closed at US$646.47, with returns of 25.0% over 7 days, 71.2% over 30 days, 105.0% year to date, and a very large 1 year gain of 661.0% that is roughly 7x. Recent headlines have focused on Micron Technology's position within the semiconductor industry and its role in supplying memory and storage for...

Diebold Nixdorf (DBD) is back on investors’ radar after VyStar Credit Union expanded its use of the company’s Branch Automation Solutions, alongside a recent first quarter update that showed revenue of US$891.8 million and net income of US$5 million. See our latest analysis for Diebold Nixdorf. The recent VyStar contract and first quarter update come after a strong run in the stock, with a 23.37% year to date share price return and a 70.17% total shareholder return over the past year,...

AI is no longer just about the mega caps at the top of every headline. With central banks reacting to inflation, oil prices swinging on Middle East tensions, and trade patterns shifting from China to Europe and beyond, smaller AI focused stocks are where early product ideas, niche data tools, and automation platforms are being built. This AI Small Caps screener is designed to filter for those under the radar opportunities that sit inside these global cross currents. In this article, you will...

Tempus AI (NasdaqGS:TEM) has completed an upsized US$400 million convertible note offering. The capital raise increases the company’s access to funding for acquisitions and investments. Shortly before the offering, Tempus AI expanded its collaboration with Quanterix/Lucent Diagnostics on Alzheimer’s disease blood tests. The Lucent Diagnostics partnership brings Tempus’ AI driven platform into neurological diagnostics alongside its existing oncology focus. For investors watching Tempus AI...

Investors may be wondering if RB Global at around US$103 a share is still offering value or if most of the upside is already priced in. The stock has been fairly steady year to date, with a 0.1% return. However, that headline number masks a 5.8% gain over the past month, a small 0.8% slip in the last week, and a return of 97.8% over three years and 85.2% over five years. Recent coverage has focused on RB Global's role in the Commercial Services sector and how investors are reacting to its...

BlackLine (NasdaqGS:BL) reported strong Q1 results, highlighting momentum across its financial automation platform. Founder Therese Tucker has retired, marking a key leadership transition for the company. Management highlighted significantly expanded adoption of BlackLine's AI-powered financial software. BlackLine focuses on software that automates and streamlines finance and accounting workflows, an area where many enterprises are still early in their digital modernization. As more...

Why Scotts Miracle-Gro is on investors’ radar Scotts Miracle-Gro (SMG) has drawn attention after its recent trading performance, with the stock showing mixed returns over the past week, month and past 3 months. This has prompted investors to reassess the lawn and garden specialist. See our latest analysis for Scotts Miracle-Gro. At a share price of $62.34, Scotts Miracle-Gro has a modest 30 day share price return of 1.43% but a weaker 90 day share price return of a 6.03% decline. Its 1 year...

Recent performance snapshot DoorDash (DASH) has drawn fresh attention after recent trading, with the stock closing at US$171.35 and showing mixed return patterns over the past month and past 3 months. See our latest analysis for DoorDash. Recent trading points to short term momentum, with a 1 month share price return of 9.91%. However, that sits against a weaker year to date share price return of a 22.04% decline and a much stronger 3 year total shareholder return of about 155%. If DoorDash’s...

Hillman Solutions Corp. recently reported first-quarter 2026 results, with sales of US$370.07 million versus US$359.34 million a year earlier, while posting a net loss of US$4.73 million and basic and diluted loss per share of US$0.02 from continuing operations. Alongside completing a US$22.51 million share repurchase program, management raised full‑year 2026 net sales guidance to a range of US$1.63 billion to US$1.73 billion, signaling increased confidence in the company’s revenue outlook...

In April 2026, Graham Corporation filed a shelf registration for up to US$56.78 million of common stock, covering 599,808 shares, providing the company with flexible access to capital. This move comes as Graham’s operations benefit from improving defense demand, a growing backlog, and higher-value programs that have supported stronger profitability and cash generation. Now we’ll explore how the new shelf registration, alongside rising analyst optimism, could influence Graham’s existing...